Patent intelligence · US
US 11857524
Stable oral suspensions of baclofen
Stable oral suspensions of baclofen
Patent details — US 11857524
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 2, 2024
- Expiration
- Dec 28, 2043
- Applicant
- ANI Pharmaceuticals, Inc.
- Claims
- 19
- CPC classes
- A61K, A61K31/197, A61K47/36, A61K47/38
Quick answer
US 11857524 (Stable oral suspensions of baclofen) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted Jan 2, 2024. Expires Dec 28, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ANI Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K31/197, A61K47/36, A61K47/38, A61K9/0053, A61K9/0095
More from ANI Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12350245
Stable oral suspensions of baclofen
granted -
US 12324787
Kits for preparing and delivering purified corticotropin
granted -
US 12233105
Methods for storing and warming purified corticotropin compositions
granted -
US 12133831
Kits for preparing and delivering purified corticotropin
granted -
US 12102662
Methods for storing and warming purified corticotropin compositions
granted -
US 11975047
Methods for storing and warming purified corticotropin compositions
granted
Frequently asked questions
What is US patent 11857524?
US 11857524 (Stable oral suspensions of baclofen) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted Jan 2, 2024. Expires Dec 28, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11857524?
ANI Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 11857524 expire?
Our index shows an expiration date of Dec 28, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.